Shujing Li

Jan 24, 2025 | onlinelibrary.wiley.com | Tao Chen |Shujing Li |Ziyuan Wang |Engineering Kunming

Conflict of Interest The authors declare no conflict of interest. Supporting Information Filename Description smll202406695-sup-0001-SuppMat.docx4.1 MB Supporting Information References 1, Science 2008, 321, 1457. 2, , Science 2020, 367, 1196. 3, Science 1999, 285, 703. 4, , , , Adv. Energy Mater. 2017, 8, 1701797. 5, , , , , , Nature 2011, 473, 66. 6, , , , , , , , , , , , Science 2021, 373, 556. 7, , , , , , , , , Adv. Funct. Mater. 2023, 33, 2302770.

Sep 30, 2024 | mdpi.com | Haonan Dai |Qi Huang |Shujing Li |Dewei Du

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

May 16, 2024 | nature.com | Hui Zhao |Shujing Li

AbstractThe aberrant activation of RAS/RAF/MEK/ERK signaling is important for KIT mutation-mediated tumorigenesis of gastrointestinal stromal tumor (GIST). In this study, we found that inhibition of RAF1 suppresses the activation of both wild-type KIT and primary KIT mutations in GIST, with primary KIT mutations showing greater sensitivity. This suggests a positive feedback loop between KIT and RAF1, wherein RAF1 facilitates KIT signaling.

Oct 12, 2023 | analyticalsciencejournals.onlinelibrary.wiley.com | Fan Xu |Jun Zhu |Ze Zhang |Shujing Li

CONFLICT OF INTEREST STATEMENT No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. We would like to declare that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. REFERENCES 1, , , , , Artif. Cells Nanomed. B 2014, 42, 323. 2, , , , , , , Anal. Chem. 2012, 84(1), 403. 3, , , , J. Dermatol. Sci. 2019, 97(1), 2.

Sep 22, 2023 | nature.com | Shujing Li |Yaming Wang

Correction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-023-00665-4, published online 07 September 2023 In this article, the ‘Contributions’ statement was incorrectly given as ‘Conceptualization, WH, and RP; methodology, YY, and LS; validation, YY, and SX; formal analysis, YY, LS, and XZ; investigation, YY; resources, LL; writing-original draft preparation, YY and LS; writing-review and editing, YY and WH; visualization, LS and RP; supervision, WH and RP; funding acquisition, WH All...